Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid

• Published in: Surgery for obesity and related diseases Vol. 13; no. 4; pp. 681 - 685
• Main Authors: Coupaye, Muriel, Calabrese, Daniela, Sami, Ouidad, Msika, Simon, Ledoux, Séverine
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.04.2017
• Subjects: Adult; Bariatric surgery; Bariatric Surgery - adverse effects; Body Mass Index; Cholagogues and Choleretics - therapeutic use; Cholelithiasis; Cholelithiasis - epidemiology; Cholelithiasis - etiology; Cholelithiasis - prevention & control; Female; Follow-Up Studies; France - epidemiology; Gallstones; Gastric bypass; Gastroenterology and Hepatology; Humans; Incidence; Male; Postoperative Complications - epidemiology; Postoperative Complications - etiology; Postoperative Complications - prevention & control; Retrospective Studies; Sleeve gastrectomy; Surgery; Ursodeoxycholic Acid - therapeutic use; Ursodeoycholic acid; Weight Loss - physiology; Gallstones; Ursodeoycholic acid; Cholelithiasis; Bariatric surgery; Gastric bypass; Sleeve gastrectomy

The use of ursodeoxycholic acid (UDCA) to prevent gallstone formation after gastric bypass (RYGB) is still debated. Furthermore, only 1 study has assessed the effectiveness of UDCA after sleeve gastrectomy (SG) with mitigated results. To compare the incidence of cholelithiasis (CL) between patients...